SPC Financial Inc. boosted its position in shares of Johnson & Johnson (NYSE:JNJ) by 208.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 11,611 shares of the company’s stock after purchasing an additional 7,851 shares during the period. SPC Financial Inc.’s holdings in Johnson & Johnson were worth $1,510,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in JNJ. Callahan Advisors LLC increased its position in Johnson & Johnson by 1.0% in the 3rd quarter. Callahan Advisors LLC now owns 102,145 shares of the company’s stock valued at $13,280,000 after acquiring an additional 979 shares in the last quarter. Independence Trust CO increased its position in Johnson & Johnson by 3.2% in the 3rd quarter. Independence Trust CO now owns 30,217 shares of the company’s stock valued at $3,928,000 after acquiring an additional 931 shares in the last quarter. Delta Asset Management LLC TN increased its position in Johnson & Johnson by 1.6% in the 3rd quarter. Delta Asset Management LLC TN now owns 27,655 shares of the company’s stock valued at $3,596,000 after acquiring an additional 443 shares in the last quarter. Penserra Capital Management LLC acquired a new stake in Johnson & Johnson in the 3rd quarter valued at about $416,000. Finally, Well Done LLC increased its position in Johnson & Johnson by 12.4% in the 3rd quarter. Well Done LLC now owns 10,888 shares of the company’s stock valued at $1,416,000 after acquiring an additional 1,199 shares in the last quarter. 65.70% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts have recently commented on JNJ shares. Credit Suisse Group set a $154.00 price target on shares of Johnson & Johnson and gave the stock an “outperform” rating in a research report on Thursday, October 19th. Vetr upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $147.40 price target for the company in a research report on Monday, January 1st. Royal Bank of Canada lifted their price target on shares of Johnson & Johnson from $144.00 to $147.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 18th. Citigroup started coverage on shares of Johnson & Johnson in a research report on Monday, September 25th. They set a “neutral” rating and a $140.00 price target for the company. Finally, Goldman Sachs Group cut shares of Johnson & Johnson from a “neutral” rating to a “sell” rating and lifted their price target for the stock from $125.00 to $130.00 in a research report on Wednesday, September 20th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $145.69.
Johnson & Johnson (JNJ) opened at $144.79 on Friday. The stock has a market cap of $388,980.00, a P/E ratio of 25.14, a P/E/G ratio of 2.67 and a beta of 0.80. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.02 and a current ratio of 1.32. Johnson & Johnson has a 1-year low of $110.76 and a 1-year high of $145.68.
Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.80 by $0.10. The firm had revenue of $19.65 billion during the quarter, compared to analysts’ expectations of $19.29 billion. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.68 earnings per share. equities analysts forecast that Johnson & Johnson will post 7.28 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Tuesday, February 27th will be issued a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date is Monday, February 26th. Johnson & Johnson’s dividend payout ratio is currently 58.33%.
ILLEGAL ACTIVITY WARNING: “SPC Financial Inc. Has $1.51 Million Position in Johnson & Johnson (JNJ)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/12/spc-financial-inc-has-1-51-million-position-in-johnson-johnson-jnj.html.
Johnson & Johnson Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.